PRWeb Further good news for the U.S. economy surfaced today as the Commercial Finance Association (CFA) released its Quarterly Asset-Based Lending (ABL) Index Q3 2014, showing American businesses utilized 43.4% of their credit lines during the 3rd ... Street Sweeper, 2 days ago
Cannabis Science Advances its Move into African Market from HIV to Cancer to the Ebola Virus With a Series of High-Level Meetings in Washington, D.C.
COLORADO SPRINGS, Colo. On Tuesday, Cannabis Science President & CEO Raymond C. Dabney The CFA delegation included Melvin Foote "The meetings went very well. From HIV to Cancer to the Ebola virus, it's clear that Africa Priority issues ...Benzinga.com, 3 days ago
The CFA Institute talks CFA exams The December sitting for the CFA Level I exams is fast approaching. As we noted last week, many will fail . In most years, the December pass rate is way below the June pass rate sometimes significantly so (e.g.EFinancialCareers Netherlands, 3 days ago
By Grant Zeng, CFA OTC:GOVX Revenue for 3Q14 ended September 2014 was $322,086, compared to net revenue of $1,004,211 for 3Q13. These revenues were related to grants from the NIH in support of its HIV/AIDS vaccine development efforts. As of ...Yahoo! Finance, 2 days ago PBIO Reports 14% Product Revenue Growth for 3Q14 Yahoo! Finance, 4 days ago
By Jason Napodano, CFA OBB:OMBP On November 19, 2014, Omni Bio Pharmaceuticals, Inc. ( OMBP ) presented data from a Phase 1 clinical trial studying the effects of a single dose of plasma-derived alpha-1 antitrypsin (p-AAT) in ten patients post ...Yahoo! Finance, 2 days ago
After being stuck on the runway for more than two years, demand is looking up. By Matthew Young, CFA | 11-21-14| 06:00AM| Airfreight demand began improving in the second half of 2013, and trends have stayed ...Morningstar.com, 2 days ago
By Brian Marckx, CFA OTC:FPMI We have updated our report on FluoroPharma Medical ( FPMI ). See below for free access to our full report on the company. Development of FluoroPharma's CardioPET nuclear imaging agent continues in the phase II ...Yahoo! Finance, 3 days ago
By Jason Napodano, CFA OTC:AMBS Amarantus Acquires Rights To Engineered Skin Substitute On November 17, 2014, Amarantus Bioscience Holdings, Inc. ( AMBS ) announced that it has entered into an exclusive option agreement with Lonza ...Yahoo! Finance, 4 days ago
By Jason Napodano, CFA OTC:CYNAF TSXV:CTH APL-130277 Shows Clear Proof-of-Concept In Phase 2 Trial On November 19, 2014, Cynapsus Therapeutics Inc. ( CYNAF ) ( CTH.V ) announced what looks to be a clear demonstration of proof-of-concept via ...Yahoo! Finance, 4 days ago
By Larry Cao, CFA China's phenomenal economic growth is no news to anyone. Many investors, however, missed out on the action as they did not feel they knew enough to get started. I recently met with veteran China stock fund manager Martin Lau at ...Seeking Alpha, 4 days ago
on your WebpageAdd Widget >Get your members hooked!